Total Payments
$368,637
2024 Payments
$51,113
Companies
11
Transactions
473
Medicare Patients
5,295
Medicare Billing
$614,345
Payment Breakdown by Category
Other$339,204 (92.0%)
Travel$17,081 (4.6%)
Food & Beverage$6,633 (1.8%)
Consulting$5,625 (1.5%)
Education$94.55 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $339,204 | 303 | 92.0% |
| Travel and Lodging | $17,081 | 66 | 4.6% |
| Food and Beverage | $6,633 | 97 | 1.8% |
| Consulting Fee | $5,625 | 3 | 1.5% |
| Education | $94.55 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $207,250 | 202 | $0 (2024) |
| Lilly USA, LLC | $160,582 | 251 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $500.00 | 2 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $108.87 | 8 | $0 (2019) |
| Medtronic MiniMed, Inc. | $70.67 | 4 | $0 (2019) |
| Shire North American Group Inc | $37.65 | 1 | $0 (2017) |
| Medtronic, Inc. | $26.15 | 1 | $0 (2023) |
| Insulet Corporation | $21.35 | 1 | $0 (2023) |
| Valeritas, Inc. | $14.92 | 1 | $0 (2019) |
| Radius Health, Inc. | $14.50 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,113 | 82 | Lilly USA, LLC ($45,845) |
| 2023 | $76,927 | 117 | Lilly USA, LLC ($55,254) |
| 2022 | $70,817 | 73 | Lilly USA, LLC ($37,120) |
| 2021 | $52,619 | 43 | Novo Nordisk Inc ($52,619) |
| 2020 | $19,202 | 18 | Novo Nordisk Inc ($18,702) |
| 2019 | $17,790 | 25 | Novo Nordisk Inc ($17,735) |
| 2018 | $80,044 | 113 | Novo Nordisk Inc ($57,516) |
| 2017 | $126.46 | 2 | Novo Nordisk Inc ($88.81) |
All Payment Transactions
473 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $92.74 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $875.00 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| 09/26/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $620.43 | General |
| 09/13/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| 09/09/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| 09/05/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| 08/30/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| 08/29/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| 08/27/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| 08/20/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| 08/15/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| 08/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| 08/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.09 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Lilly USA, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| 07/25/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $80.69 | General |
| 07/25/2024 | Lilly USA, LLC | — | Travel and Lodging | Cash or cash equivalent | $38.92 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,535 | 4,533 | $428,260 | $161,614 |
| 2022 | 18 | 1,061 | 4,074 | $417,150 | $159,521 |
| 2021 | 21 | 1,124 | 4,024 | $420,887 | $160,945 |
| 2020 | 21 | 1,575 | 4,110 | $408,600 | $132,265 |
Total Patients
5,295
Total Services
16,741
Medicare Billing
$614,345
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 498 | 918 | $251,532 | $93,695 | 37.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 27 | 2,161 | $69,152 | $38,721 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $22,660 | $7,415 | 32.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 76 | 144 | $17,136 | $3,991 | 23.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 106 | 152 | $10,488 | $2,453 | 23.4% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 11 | 12 | $7,944 | $1,677 | 21.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 128 | 200 | $3,000 | $1,672 | 55.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 86 | 127 | $6,985 | $1,650 | 23.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 112 | 160 | $6,400 | $1,625 | 25.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 43 | 52 | $6,292 | $1,480 | 23.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 26 | 31 | $5,239 | $1,254 | 23.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $1,652 | $1,007 | 61.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 77 | 113 | $3,616 | $844.71 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,068 | $813.10 | 39.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 64 | 83 | $3,320 | $774.98 | 23.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 52 | $3,744 | $606.30 | 16.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 54 | 68 | $2,516 | $592.28 | 23.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $700.00 | $475.58 | 67.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 50 | 82 | $1,968 | $452.80 | 23.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 51 | 84 | $1,848 | $416.56 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 488 | 980 | $268,520 | $100,991 | 37.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 26 | 2,160 | $69,120 | $36,178 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $18,540 | $6,564 | 35.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 70 | 163 | $19,397 | $4,611 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $6,222 | $2,429 | 39.0% |
About Dr. Atara Schultz, MD
Dr. Atara Schultz, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Teaneck, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912112731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Atara Schultz, MD has received a total of $368,637 in payments from pharmaceutical and medical device companies, with $51,113 received in 2024. These payments were reported across 473 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($339,204).
As a Medicare-enrolled provider, Schultz has provided services to 5,295 Medicare beneficiaries, totaling 16,741 services with total Medicare billing of $614,345. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Teaneck, NJ
- Active Since 05/14/2007
- Last Updated 12/19/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1912112731
Products in Payments
- MOUNJARO (Drug) $112,042
- Ozempic (Drug) $92,205
- RYBELSUS (Drug) $48,787
- Rybelsus (Drug) $32,425
- TRULICITY (Drug) $22,363
- Tresiba (Drug) $18,703
- Xultophy 100/3.6 (Drug) $2,611
- Victoza (Drug) $1,814
- t:slim X2 insulin pump (Device) $500.00
- TOUJEO (Drug) $94.03
- Minimed 670G System (Device) $70.67
- NATPARA (Drug) $37.65
- MINIMED 780G (Device) $26.15
- Omnipod (Device) $21.35
- V-GO (Device) $14.92
- SOLIQUA (Drug) $14.84
- Tymlos (Biological) $14.50
- Belviq (Drug) $11.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Teaneck
Dr. Mark Wiesen, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $34,099
Endocrinology, Diabetes & Metabolism $34,099
Dr. Ari Eckman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $6,442
Endocrinology, Diabetes & Metabolism $6,442
Dr. Deeksha Mehta, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $308.07
Endocrinology, Diabetes & Metabolism $308.07